On May 7, 2025, Opal Bidco SAS and Clayton, Dubilier & Rice Fund XII, L.P. (together referred to as the Acquirer) formally announced an open offer to acquire up to 59,87,962 fully paid-up equity shares of Sanofi Consumer Healthcare India Limited (referred to as the Target Company), representing 26% of the company's voting share capital. This offer is made to the public shareholders of the Target Company, in compliance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (as amended), also known as SEBI (SAST) Regulations.

Details of the Open Offer

As of May 7, 2025, a total of 21,92,768 equity shares, which represent 36.62% of the offer size, have been tendered into the Open Offer Escrow Demat Account. These shares were deposited with Ventura Securities Limited, with the depository participant identification number IN303116 and client identification number 15236516. The PAN associated with the escrow account is ABKCS7912D.

Furthermore, on the same date, 3,62,149 equity shares were tendered, representing 6.05% of the total offer size, into the escrow account. These shares will be subject to the usual validation and verification processes as per the terms outlined in the Letter of Offer (LoF) dated April 12, 2025.

It is important to note that capitalized terms not defined in the current disclosure have the meanings ascribed to them in the Letter of Offer (LoF). The shares that have been tendered by the public shareholders will be subject to the submission of a complete set of documents, as applicable.

Acceptance of Shares and Further Procedures

The equity shares that have been tendered will undergo a thorough process of validation and verification to ensure that they meet the regulatory requirements. Only those validly tendered shares will be considered for acceptance in the open offer. Therefore, the number of shares tendered may not align with the final number of shares accepted by the Acquirer, as per the SEBI (SAST) Regulations.

This open offer is part of the ongoing transaction involving Opal Bidco SAS and Clayton Dubilier & Rice Fund XII, which aims to acquire a significant stake in Sanofi Consumer Healthcare India Limited. The process of tendering and validation continues as the public shareholders respond to the offer and provide the necessary documents.

Disclosure on BSE Website

As per the requirements, the listing department of BSE has been formally notified about this open offer and the status of shares tendered so far. The information has been shared for public dissemination to ensure transparency and compliance with market regulations.

The Upcoming IPOs in this week and coming weeks are Virtual Galaxy Infotech, Wagons Learning.

The Closed IPOs are Srigee DLM, Manoj Jewellers.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.